FDA Nod For JAZZ's Drug, BYSI's PROTECTIVE-2 Trial Meets Goals, EDSA To Begin COVID-19 Drug Trial

Today's Daily Dose brings you news about Momenta Pharma's positive results from myasthenia gravis trial; BeyondSpring's phase III trial results of Plinabulin in chemotherapy-induced neutropenia; Edesa's progress in COVID-19 drug trial; FDA approval of Jazz Pharma's Zepzelca and Celldex Therapeutics' stock offering.

from RTT - Biotech https://ift.tt/2UN8AW9
via IFTTT